The University of Health Sciences and Pharmacy in St Louis Board of Trustees has named David D Allen, RP., PhD, FASHP, FNAP, FAPhA, as its new president effective 1 July 2021, it was reported on Wednesday.
Allen has served as dean of the School of Pharmacy, professor of biomolecular sciences and executive director of and research professor in the Research Institute of Pharmaceutical Sciences at the University of Mississippi. He was dean of pharmacy at the Northeast Ohio Medical University College of Pharmacy, formerly Northeastern Ohio Universities College of Pharmacy, in Rootstown, Ohio, and associate dean of curricular affairs at the Texas Tech University Health Sciences Center School of Pharmacy in Amarillo, Texas. He was also a professor of physiology and pharmacology in NEOMED's College of Medicine while he was the dean of pharmacy.
Allen is to succeed John A Pieper, PharmD, FCCP, FAPhA, FFIP.
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
OncoHost receives BIG Innovation Award in Health category
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees